Category: Finance
-
Challenge Seeks Gastrointestinal Toxicity Test Methods
A challenge competition on InnoCentive sponsored by AstraZeneca is looking for new lab tests for toxic effects of drugs on the gastrointestinal tract.
-
Gene Silencing Treatments Licensed for Heart Disease
Biopharmaceutical company Amgen is acquiring the rights to a technology that stops the actions of inherited genes associated with a leading type of heart disease.
-
Harvard Spin-Off to Sequence, Visualize RNA in Tissue
A new spin-off enterprise from Harvard University is commercializing technology that enables sequencing and imaging of genetic transcriptions of cells in their original tissue.
-
Spinal Cord Injury Rehab Device in Development
A robotic device to improve the balance of people going through rehabilitation after spinal cord injury is being developed by an engineering-medical team from Columbia University and University of Louisville.
-
DoD Grant Funds Exosome Manufacturing Process
A biotechnology company is receiving a Department of Defense grant to develop a commercial-scale manufacturing process for exosomes, tiny bubbles that deliver drugs to cells in the body.
-
Spin-Off Companies to Develop Chronic Disease Therapies
Two new spin-off enterprises are being created to develop gut-based treatments for chronic diseases using technologies from synthetic biology company Intrexon Corporation.
-
Health Agency Funds Drug-Resistant Bacteria R&D
Biomedical Advanced Research and Development Authority, or BARDA, signed agreements worth $67 million to develop new treatments and diagnostics for urgent drug-resistant infections.
-
FDA Holding Opioid Overdose App Competition
The U.S. Food and Drug Administration is seeking a smartphone app that can quickly find a source of the antidote drug naloxone for someone having an opioid overdose.
-
Small Business Grant Funds Natural Dyes Crop Research
A company making natural dyes for clothing and a plant science research center are discovering genomic processes to improve plants producing indigo, the dye giving blue jeans its color.
-
Computational Drug Discovery Company Launches
A new enterprise, Relay Therapeutics, is being formed for computer-driven discovery of new drugs based on the movements and interactions of protein molecules.